Matt Feinstein to direct AHA-funded SFRN center on Inflammation in Cardiac and Neurovascular Disease, focusing on understanding inflammatory responses and treating heart disease caused by inflammation.
Research teams at Feinberg will undertake three projects on inflammation in heart failure with preserved ejection fraction (HFpEF), aiming to analyze immune cell regulation and develop approaches to target inflammation in the disease.
HFpEF, marked by excessive inflammation, accounts for over half of U.S. heart failure cases with significant mortality rates; research aims to modulate metabolism and immune responses to tackle inflammation in HFpEF.
Collection
[
|
...
]